Today: 28 June 2026
Browse Category

NASDAQ:DNLI 10 December 2025 - 29 January 2026

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
····
US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

US Stock Market Top Losers Today (December 10, 2025): Polestar, AeroVironment, Denali, Uber and AutoZone Tumble After the Bell

Polestar Automotive shares dropped 25.1% Wednesday after a 1-for-30 reverse stock split and trading halt, with analysts citing ongoing losses and debt concerns. The S&P 500 and Dow hit new highs following a Fed rate cut, but several high-profile stocks, including AeroVironment and Denali Therapeutics, also posted double-digit declines. Microcaps like Work Medical Technology plunged over 85%.
10 December 2025
········
Top Pre‑Market Losers Today (December 10, 2025): AFJK, CBRL, DNLI & AEG Lead Early Declines Before the Bell

Top Pre‑Market Losers Today (December 10, 2025): AFJK, CBRL, DNLI & AEG Lead Early Declines Before the Bell

Aimei Health Technology plunged nearly 50% in pre-market trading after extending its business-combination deadline. Lion Group Holding and JX Luxventure Group each dropped over 35%. Broader U.S. stock futures showed little movement as investors awaited the Federal Reserve’s rate decision later today. Cracker Barrel and Denali Therapeutics also traded lower on fresh news and analyst calls.
10 December 2025
····

Stock Market Today

  • Top ETFs Holding SpaceX Stock After Its Historic IPO
    June 28, 2026, 11:05 AM EDT. SpaceX (NASDAQ: SPCX) debuted in the largest IPO on record but has dropped 23.4% in its first two weeks, highlighting the benefits of owning the stock via exchange-traded funds (ETFs) to reduce volatility. Nearly 110 ETFs hold SpaceX shares, with 27 featuring it among their top 15 holdings. Notable options include Fidelity Nasdaq Composite Index ETF (ONEQ), which tracks the broader Nasdaq Composite and holds SpaceX at 2.5% of its $10.9 billion portfolio with a low 0.21% expense ratio. Sector ETFs, particularly in communication services and aerospace, may increase exposure. ETFs offer diversified ways for investors to access SpaceX without direct stock volatility after its tumultuous IPO.

Latest articles

Intel (NASDAQ:INTC) edges lower, pulling back from $700 billion mark

Intel (NASDAQ:INTC) edges lower, pulling back from $700 billion mark

28 June 2026
Intel shares plunged 9.3% from Monday’s 52-week high, erasing $66 billion in market value and falling back below the $700 billion threshold as chip stocks tumbled on AI spending worries, with trading volume far outpacing short interest and sector profitability questions intensifying.
Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

28 June 2026
Ondas Inc. (NASDAQ:ONDS) plunged 15.5% last week to $7.83 despite joining the Russell 3000 Index and announcing $40M+ in new defense orders; a June 26 filing registered 3.38M acquisition shares for resale, equal to 0.64% of shares, setting up a key test of real demand versus supply as index-driven volume fades ahead of the July 3 market holiday.
NVDA selloff drags $74 billion equity stake into spotlight

NVDA selloff drags $74 billion equity stake into spotlight

28 June 2026
Nvidia plunged 8.6% last week to $192.53, wiping out about $443 billion in equity value, as chip stocks suffered their worst week since April and Nvidia’s massive equity investment book added new risk to quarterly results; a further drop to $189.23 would mark a 20% slide from its May high.
Go toTop